Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 1
2001 1
2014 1
2015 1
2020 1
2021 1
2022 1
2024 1
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean girault c (193 results)?
Multisystemic Effects of Elexacaftor-Tezacaftor-Ivacaftor in Adults with Cystic Fibrosis and Advanced Lung Disease.
Burgel PR, Paillasseur JL, Durieu I, Reynaud-Gaubert M, Hamidfar R, Murris-Espin M, Danner-Boucher I, Chiron R, Leroy S, Douvry B, Grenet D, Mely L, Ramel S, Montcouquiol S, Burnet E, Ouaalaya EH, Sogni P, Da Silva J, Martin C; Participating Investigators of the French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Ann Am Thorac Soc. 2024 Jul;21(7):1053-1064. doi: 10.1513/AnnalsATS.202312-1065OC. Ann Am Thorac Soc. 2024. PMID: 38579175
Real-Life Safety and Effectiveness of Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis.
Burgel PR, Munck A, Durieu I, Chiron R, Mely L, Prevotat A, Murris-Espin M, Porzio M, Abely M, Reix P, Marguet C, Macey J, Sermet-Gaudelus I, Corvol H, Bui S, Lemonnier L, Dehillotte C, Da Silva J, Paillasseur JL, Hubert D; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Am J Respir Crit Care Med. 2020 Jan 15;201(2):188-197. doi: 10.1164/rccm.201906-1227OC. Am J Respir Crit Care Med. 2020. PMID: 31601120
Rapid Improvement after Starting Elexacaftor-Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease.
Burgel PR, Durieu I, Chiron R, Ramel S, Danner-Boucher I, Prevotat A, Grenet D, Marguet C, Reynaud-Gaubert M, Macey J, Mely L, Fanton A, Quetant S, Lemonnier L, Paillasseur JL, Da Silva J, Martin C; French Cystic Fibrosis Reference Network Study Group. Burgel PR, et al. Am J Respir Crit Care Med. 2021 Jul 1;204(1):64-73. doi: 10.1164/rccm.202011-4153OC. Am J Respir Crit Care Med. 2021. PMID: 33600738
Central venous thrombosis and thrombophilia in cystic fibrosis: A prospective study.
Munck A, Kheniche A, Alberti C, Hubert D, Martine RG, Nove-Josserand R, Pin I, Bremont F, Chiron R, Couderc L, Dalphin ML, Darviot E, Delaisi B, Dominique S, Durieu I, Fanton A, Fayon M, Gérardin M, Giniès JL, Giraut C, Grenet D, Guillot M, Huet F, Le Bourgeois M, Murris-Epin M, Ramel S, Sardet A, Sermet-Gaudelus I, Varaigne F, Wanin S, Weiss L, Hurtaud MF. Munck A, et al. Among authors: giraut c. J Cyst Fibros. 2015 Jan;14(1):97-103. doi: 10.1016/j.jcf.2014.05.015. Epub 2014 Aug 5. J Cyst Fibros. 2015. PMID: 25107684 Free article.
Using chest computed tomography and unsupervised machine learning for predicting and evaluating response to lumacaftor-ivacaftor in people with cystic fibrosis.
Campredon A, Battistella E, Martin C, Durieu I, Mely L, Marguet C, Belleguic C, Murris-Espin M, Chiron R, Fanton A, Bui S, Reynaud-Gaubert M, Reix P, Hoang-Thi TN, Vakalopoulou M, Revel MP, Da Silva J, Burgel PR, Chassagnon G; Participating investigators in the French CF reference network study group:; Mounard J, Poulet C, Rames Amiens C, Person C, Troussier F, Urban Angers T, Dalphin ML, Dalphin JC, Pernet D, Richaud-Thiriez Besançon B, Bui S, Fayon M, Macey-Caro Bordeaux J, Campbell K, Laurans Caen M, Borderon C, Heraud MC, Labbé A, Montcouquiol Clermont-Ferrand S, Bassinet L, Remus Créteil N, Fanton A, Houzel-Charavel A, Huet F, Perez-Martin Dijon S, Boldron-Ghaddar A, Scalbert Dunkerque M, Mely Giens L, Camara B, Llerena C, Pin I, Quétant Grenoble S, Cottereau A, Deschildre A, Gicquello A, Perez T, Stervinou-Wemeau L, Thumerelle C, Wallaert B, Wizla Lille N, Languepin J, Ménétrey C, Dupuy-Grasset Limoges M, Bazus L, Buchs C, Jubin V, Werck-Gallois MC, Mainguy C, Perrin T, Reix P, Toutain-Rigolet Lyon Pédiatrie A, Durieu I, Durupt S, Reynaud Q, Nove-Josserand Lyon Adultes R, Baravalle-Einaudi M, Coltey B, Dufeu N, Dubus JC, Stremler Marseille N, Caimmi D, Chiron Montpellier R, … See abstract for full author list ➔ Campredon A, et al. Among authors: giraut c. Eur Respir J. 2022 Jun 16;59(6):2101344. doi: 10.1183/13993003.01344-2021. Print 2022 Jun. Eur Respir J. 2022. PMID: 34795038 Free article.
Sweat chloride and lung function responses to elexacaftor-tezacaftor-ivacaftor in people with cystic fibrosis with two versus one responsive CFTR variants: an analysis of two real-world observational studies.
Burgel PR, Da Silva J, Girodon E, Durieu I, Reynaud-Gaubert M, Murris-Espin M, Chiron R, Grenet D, Ramel S, Mely L, Hamidfar R, Douvry B, Houdouin V, Audousset C, Macey J, Mittaine M, Weiss L, Cosson L, Danner-Boucher I, Reix P, Baravalle M, Burnet E, Sermet-Gaudelus I, Martin C, Paillasseur JL; French Cystic Fibrosis Reference Network study group. Burgel PR, et al. Lancet Respir Med. 2025 Sep 3:S2213-2600(25)00190-0. doi: 10.1016/S2213-2600(25)00190-0. Online ahead of print. Lancet Respir Med. 2025. PMID: 40914184
[Bronchiectasis in young adults in the navy].
HEBRAUD Y, DUVAL C, GIRAUT C. HEBRAUD Y, et al. Among authors: giraut c. Bull Mens Soc Med Mil Fr. 1955 Apr;49(4):86-91. Bull Mens Soc Med Mil Fr. 1955. PMID: 14389887 French. No abstract available.